Inflammation has been associated with cardiovascular events and mortality, using C-reactive protein (CRP) as a marker. We examined whether the baseline serum concentration of CRP can independently predict the development of hypertension or future systolic or diastolic blood pressure (BP) in a community-based population in Taiwan.
C-reactive protein (CRP) is a marker of chronic inflammation that has been associated with stroke and coronary heart disease (CHD)-related events. However, the association observed between CRP and hypertension has been inconsistent among studies. A positive association of CRP with hypertension was observed in the Multi-Ethnic Study of Atherosclerosis (MESA), 1 the Women's Health Study, 2 the Kuopio Ischemic Heart Disease Risk Factor Study, 3 and the Rotterdam study. 4 However, no association between baseline CRP and the development of hypertension was observed in the Strong Heart Study, 5 and there appears to be no association between CRP and hypertension in individuals with Type 1 diabetes mellitus 6 or in postmenopausal women. 7 Most prospective studies in white populations have shown a significant association between CRP and the development of hypertension. 2, 3, 8 However, to date there have been few prospective studies of such an association 9 conducted in Asian populations. The incidence and distribution of risk factors for cardiovascular disease (CVD) differs with ethnicity. 10 In particular, levels of CRP are known to differ markedly in different ethnic groups. 11 For example, individuals of African ancestry have higher levels of CRP, and Asians appear to have lower levels of CRP, than do white people. 11 Baseline blood pressure (BP) is the most important predictor of future hypertension. 12 Because most prospective studies of the effect of CRP on incident hypertension did not adjust for baseline BP, it is unclear whether the association between baseline CRP and future hypertension is independent of baseline BP. Moreover, it remains unclear whether consideration of CRP in addition to other important risk factors improves the prediction of hypertension. We therefore conducted a prospective study of the association of CRP with the development of hypertension independent of the effects of obesity and baseline BP. In addition, we evaluated the predictive value of CRP for hypertension in a Chinese community-based study.
METHODS

Study population
The CardioVascular Disease risk FACtors Two-township Study (CVDFACTS) is a community-based follow-up study in Taiwan focusing on CVDs and their risk factors. From 1991-1993, all residents ≥ 3 years of age in 5 villages in Chu-Dung township and 5 villages in Pu-Tzu township were invited to participate in the baseline examination. A total of 6,312 people participated (2,902 males and 3,410 females), corresponding to 20% of the population. 13 Of these participants, 5,040 were ≥ 20 years of age. The follow-up examination was performed between 1994 and 1997. At the study baseline, there were 3,299 adults without diabetes or hypertension, of whom 1,184 adults were lost to follow-up, leaving 2,115 adults who participated in the follow-up examination. The adults for whom data were analyzed were older (41.3 vs. 45.4 years, P < 0.01) and had a slightly lower mean SBP (108 mm Hg vs. 110 mm Hg, P < 0.01), DBP (70 mm Hg vs.71 mm Hg, P < 0.01), and body mass index (BMI) (22.9 kg/m 2 vs. 23.3 kg/m 2 , P < 0.01) than the adults lost to follow-up. After excluding 2 adults with very high levels of CRP (≥ 10 mg/dl), 2,113 eligible adults ≥ 20 years of age were included in the analysis ( Figure 1 ). All participants gave informed consent for their participation in the study at baseline and follow-up. Further details about sampling and data collection for the study have been described previously. 14 The study was approved by the Institute Review Board of the National Health Research Institutes, Taiwan.
Definitions of variables
Hypertension 15 was defined as an SBP 140 mm Hg, a DBP 90 mm Hg, or the use of antihypertensive medications. Prehypertension 15 was defined as an SBP of 120-139 mm Hg or a DBP of 80-89 mm Hg. Subjects with an SBP/DBP under 120/80 mm Hg were used as the reference group for the study. 15 Diabetes mellitus was defined as a fasting glucose 126 mg/dl (7.0 mmol/l) or the use of antidiabetic medication. 16 The definitions of central obesity (waist circumference 90 cm in men and 80 cm in women), elevated triglycerides ( 150 mg/dl), and reduced high-density lipoprotein cholesterol (HDL-C) (< 40 mg/dl in men and < 50 mg/dl in women) were based on the definitions provided in the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). 17 Obesity was defined as a BMI ≥ 25 kg/m 2 on the basis of the definition used by the AsianPacific obesity task force of the World Health Organization (WHO). 18 Examinations were performed in the study clinic in each of the two townships. Weight, height, and waist circumference were measured while participants were dressed in light street clothes and without shoes. 19 Blood pressure was measured three times after the subject had been seated for 5 minutes, and the mean of the last two readings was used for analysis. All subjects were asked to fast overnight for 8 hours before blood-specimen collection; blood specimens were stored immediately at -70 ºC and analyzed within 1 month after their collection. Fasting glucose and triglycerides were measured on stored specimens after thawing at room temperature. The homogeneous method 20 was used to measure HDL-C. We measured the levels of CRP with a commercial kit (Diagnostica Stago, Paris, France). The coefficient of variation (CV) for CRP was 7.72%.
Individuals attending the baseline and follow-up examinations also completed a questionnaire-based interview. The questionnaire contained items on demographic data, lifestyle, self-reported health conditions, and family history of disease. Participants who answered "Yes" to the question "Did a doctor ever tell your father/mother/brother/sister that they had hypertension?" were considered to have a family history of hypertension.
The participants' intake of calcium was assessed with the Food Frequency Questionnaire (FFQ), which included 49 food items for 8 food groups (milk and soymilk, vegetables, fruits, meat, egg and soybean products, seafood, beverages, and beverages with a low alcohol content containing vitamin B complex). In addition, information on the types, amounts, and frequency of intake of staple foods, cooking oils, and supplements; discretionary use of sugar and butter/margarine/mayonnaise; and avoidance of eating fat, egg yolks, and skin from meat was collected through open-ended questions. 21 Urine sodium was measured to assess sodium intake, with adjustment for urine creatinine. 
Statistical methods
We classified the study population sample into three groups based on tertiles of CRP among normotensive individuals. Means and standard deviations (SD) of various baseline characteristics are presented for these three tertile groups. The trend test was used to evaluate the trend relationships between risk factors for CVD and CRP. The incidence rate of hypertension was calculated by dividing the number of new events by the total years of follow-up during the follow-up period. Survival analysis was used to investigate the association between baseline CRP and future hypertension. Survival time was calculated as the time in years between the baseline and follow-up visits in the study. We performed a weighted least-squares regression to test for multicollinearity and combined components of the metabolic syndrome into an index to avoid multicollinearity in the regression model. 22 Linear regression with stepwise selection was used to evaluate independent predictors of incident SBP/DBP and PP. We also estimated the association between high CRP and hypertension in both sexes, in young (20-39.9 years), middle-aged (40-64.9 years), and older age groups (≥ 65 years), and in obese (BMI ≥ 25 kg/m 2 ) and nonobese adults (BMI < 25 kg/m 2 ). "Independently associated" was commonly used in the epidemiologic component of the study when a variable was significantly associated with outcome despite the existence of other variables. The discrimination among differential models was evaluated with receiver operating characteristic (ROC) curves. The comparisons among the areas under the curve of the ROCs were made with a nonparametric method developed by DeLong et al. 23 We further used the net reclassification index and integrated discrimination index to evaluate the improvement in the accuracy of CRP for predicting future hypertension. 24 All statistical analyses were done with SAS version 9.2 (SAS Institute, Cary, NC).
RESULTS
C-reactive protein and incident hypertension
A total of 145 participants (male 41.4%) developed hypertension between the baseline (1990-1993) and the latest follow-up survey (1994-1997) in the study. The incidence of hypertension was 20.6 per 1,000 person-years (PYs) (20.8 for men and 20.5 per 1,000 PYs for women, P = 0.9365). Hypertensive participants were more likely to be older, more obese, and to have more abdominal obesity, a higher SBP/DBP, higher triglycerides and fasting glucose, and a lower HDL-C than those who were normotensive (Table 1) . Baseline characteristics of the study sample by CRP tertile are presented as means or proportions in Table 2 . Age, BMI, waist circumference, SBP/DBP, triglycerides, HDL-C, and fasting glucose were all associated with CRP level (All P-values for trend < 0.05). The associations between smoking (P for trend = 0.0866), a family history of hypertension (P for trend = 0.0603), and CRP were borderline significant.
The incidence rates of hypertension by increasing tertile of CRP were 9.3, 19.0, and 33.0 per 1,000 PYs (P for trend <.0001). The univariate hazard ratios (HRs) and 95% confidence intervals (CIs) for incident hypertension were 2.07 (1.23-3.49), respectively, for participants in the middle tertile of CRP, and 3.38 (2.08-5.48), respectively, for those in the upper tertile of CRP, as compared with those in the lowest tertile of CRP. Moreover, as compared with participants in the lowest tertile of CRP, participants in the highest tertile of CRP had about a 2-fold greater risk of hypertension after adjustment was made for central obesity and general obesity. After further control for age, sex, number of components of metabolic syndrome, family history of hypertension, and high urine sodium (≥ 1.1 (median), adjusted for urine creatinine), the HRs and respective 95% CIs for incident hypertension were 1.43 (0.84-2.41) for participants in the middle tertile of CRP and 1.69 (1.02-2.81) for those in the upper tertile of CRP, as compared to those in the lowest tertile. There was a trend toward a relationship between CRP and incidence of hypertension, but this was not significant (P = 0.07) ( Table 3) .
We further conducted a stratified analysis to estimate the association between high CRP (≥ 0.5 mg/l) and incident hypertension in the multivariate model, with adjustment for metabolic syndrome; high urine sodium (adjusted for urine creatinine); family history of hypertension in males and females; young, middle, and older age; and Obesity and absence of obesity. The HRs and respective 95% CIs for high CRP and incident hypertension were 1. 
Predictive power of C-reactive protein for incident hypertension
In addition to investigating the association of CRP with hypertension, we evaluated whether CRP could improve the prediction of incident hypertension. To do this, we used the ROC net reclassification improvement index (NRI) and integrated discrimination index (IDI) to evaluate the predictive power of CRP for improving prediction of the onset of hypertension beyond that based on known risk factors for the condition. The use of CRP provided some additional information for predicting hypertension when obesity was included in the model. Although CRP was significantly associated with the development of hypertension, it only slightly improved the ability to predict hypertension as evaluated with IDI (Table 3 , Model 6). We further tested the equality of the predictive power for hypertension of CRP and that of metabolic syndrome, when the model contained both SBP and DBP. We found similar predictive powers of CRP and of metabolic syndrome in models adjusted for age and gender (0.7566 vs. 0.7647, P > 0.05).
C-reactive protein, systolic/diastolic blood pressure, and pulse pressure
We also performed multiple linear modeling in which, in separate models, we made SBP, DBP, and mean Pulse pressure (PP) the dependent variables (Table 4) . This showed age, SBP, DBP, HDL-C, family history of hypertension, and CRP (beta = 0.704, P < 0.01) as all being independent predictors of followed SBP (Model 1). C-reactive protein was also significantly associated with PP (beta = 0.633, P < 0.01) independently of baseline SBP and DBP (Model 3). However, CRP was not independently associated with DBP (Model 2).
We also performed stratified analyses for the multivariate linear regressions. This showed CRP to be associated with SBP and PP in both sexes, in adults with and without obesity, and in middle-aged and older adults, but not in young adults (Figure 2A,C) . There was no association of CRP with DBP in any group ( Figure 2B ).
DISCUSSION
The inflammatory marker CRP was significantly associated with SBP and PP in the follow-up visits in the study, independent of baseline SBP/DBP and obesity, in the Chinese population in Taiwan that participated in the study.
Obesity is associated with increased levels of proinflammatory cytokines, including interleukin-6 and tissue necrosis factor-alpha, which increase circulating levels of CRP. Because of this, obesity is a major potential confounder of the association between CRP and BP. 25 The MESA study also found that CRP predicted incident hypertension independently of obesity. 1 The association between CRP and hypertension was attenuated by controlling for obesity. However, the association between obesity and hypertension is not altered by adjusting for inflammatory markers. 1 In the present study we also found that CRP was associated with future SBP independent of central obesity.
Baseline BP is the most important predictor of future hypertension. 26 Most prospective studies of the relationship between baseline CRP and incident hypertension did not adjust for baseline BP. 27 Therefore, it has so far remained unclear whether CRP can predict the development of hypertension independently of baseline BP. We demonstrated in the present study that CRP significantly predicted the development of hypertension, an elevated SBP, and an elevated PP. These findings are similar to those of the Women's Health Study, 28 which also found that CRP significantly predicted incident hypertension independently of baseline SBP and DBP.
The relationship of CRP to SBP/DBP and PP has remained unclear. Cross-sectional studies have shown a significant, independent association between high BP and plasma levels of CRP, and increases in PP and SBP were found to be associated with elevated levels of CRP among apparently healthy US adults, 27 as well as in the British Women's Heart and Health study, 29 in-never-treated hypertensive Italian subjects, 30 and in Chinese women. 31 However, there is currently little prospective data on these associations. 32 Only the Rotterdam study has supported a role of CRP in the development of isolated systolic hypertension in older adults. 4 Our study further demonstrated that baseline CRP was Figure 2 . Association (adjusted beta and 95% confidence intervals) between C-reactive protein and systolic/diastolic blood pressure (BP) and pulse pressure in stratified groups. For systolic BP, the model was adjusted for age, gender, systolic/diastolic BP, waist circumference, family history of hypertension, and calcium intake (A). For diastolic BP, the model was adjusted for age, gender, systolic/diastolic BP, waist circumference, high-density lipoprotein cholesterol, ratio of urine sodium to creatinine, and current smoking (B). For pulse pressure, the model was adjusted for age, gender, systolic/diastolic BP and family history of hypertension (C). significantly associated with future SBP and PP independent of baseline SBP and DBP. This indicates that inflammation may play a role in the development of arterial stiffness in the Chinese population. Although a positive association between CRP and incident hypertension has been reported, 2 it remains unclear whether the measurement of CRP can improve the prediction of incident hypertension. We conducted a discriminative analysis to reconfirm that baseline SBP/DBP was the most significant contributor to the prediction of hypertension. We found that CRP did not significantly improve the prediction of hypertension as based on evaluation of the ROC. However, the use of CRP did provide a slight improvement, of 0.4%, in the IDI (see Table 3 , Model 6). Furthermore, we found that in predicting hypertension, CRP was not inferior to metabolic syndrome, a prehypertensive state 33 that is associated with hypertension. 34 Therefore, the inflammatory state indicated by an elevated CRP may also be a type of prehypertensive state.
The association between CRP and SBP may differ by age. Our study showed the CRP was significantly associated with PP only in middle-aged and older adults. The CARDIA study of younger whites and African-Americans 35 reported that CRP concentrations no longer predicted hypertension in multivariate model. An elevated DBP has often been observed in young hypertensive patients, 36 and in our study baseline CRP was not independently associated with future DBP. These findings suggest that inflammation has a greater effect on incident hypertension among older than middleaged or younger members of a population.
Our study showed different results from the two analytic methods of linear regression and survival analysis. Linear regression showed that baseline CRP was significantly associated with future SBP and PP, whereas survival analysis showed that the predictive power of CRP for hypertension was only borderline significant. Outcomes with continuous variables are more sensitive in detecting significant associations than are outcomes with dichotomous variables in the same study. Different results with these two methods are frequently observed in studies of the association between exposures and diseases with low incidence rates or in which there are only small numbers of disease incidents.
Our study had some limitations. The single measurement of SBP and DBP for classifying BP status can cause misclassification bias. However, the measurement of BP and the definition of hypertension at the follow-up in the study were consistent, and the ascertainment of hypertension was not influenced by the participants' serum levels of CRP. Therefore, the misclassification of BP should be nondifferential among groups with different levels of CRP, resulting in bias toward the null. 37 In sum, we conclude that inflammation may increase the risk of hypertension and that inflammatory markers can be useful for identifying groups at high risk of hypertension.
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